VCYT

NASDAQ 已收盘

Veracyte

40.14 USD
-1.07-2.60%
盘后 40.12 -0.05%
2026-09-15
市值
$3.10B
市盈率
27.61
EPS
1.39
股息率
52 周区间
29.46 – 60.91
成交量
1.76M
Beta
1.93
目标价
58.42
52W 低 29.4652W 高 60.91
价格走势

公司简介

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its n...